Please provide your email address to receive an email when new articles are posted on . “What we found with this prep, which is the lowest volume prep on the market today, is that patients were quite ...

PLENVU Offers Same-Day Morning-of-Colonoscopy and 2-Day Split-Dosing 1 BRIDGEWATER, N.J., Sept. 11, 2018 /PRNewswire/ -- Salix Pharmaceuticals ("Salix"), one of the largest specialty pharmaceutical ...

Salix Pharmaceuticals aims to simplify the preparation process for colonoscopies with its new FDA-approved bowel cleanser, Plenvu, the company announced May 7. Plenvu is a liquid drug patients can ...

The approval of Plenvu was based on multiple clinical trials including the NOCT study which compared Plenvu to the trisulfate bowel cleansing solution Suprep (sodium sulfate, potassium sulfate, ...

Valeant Pharmaceuticals International, wholly owned subsidiary, Salix Pharmaceuticals, announced that the US Food and Drug Administration (FDA) accepted the New Drug Application for NER1006 (Plenvu) a ...

- Norgine B.V. today announced that the US Food and Drug Administration (FDA) has approved PLENVU® (NER1006), an osmotic laxative indicated for cleansing of the colon in preparation for colonoscopy in ...

- Norgine B.V. today announced that results from the PLENVU[®] Phase III DAYB trial were published in ENDOSCOPY, a monthly peer-reviewed medical journal on behalf of ...

BRIDGEWATER, N.J., Sept. 11, 2018 /CNW/ -- Salix Pharmaceuticals ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of ...

US launch date: second half of 2018 In Europe, PLENVU is available through Norgine Norgine B.V. today announced that the US Food and Drug Administration (FDA) has approved PLENVU (NER1006), an osmotic ...